These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36896897)

  • 1. Mogamulizumab-associated rash: A challenging case report and literature review.
    Martínez-Fernández S; Suh-Oh HJ; Couselo-Rodríguez C; Soto-García D; Álvarez C; Flórez Á
    Australas J Dermatol; 2023 May; 64(2):e191-e193. PubMed ID: 36896897
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome.
    Hirotsu KE; Neal TM; Khodadoust MS; Wang JY; Rieger KE; Strelo J; Hong E; Kim YH; Kwong BY
    JAMA Dermatol; 2021 Jun; 157(6):700-707. PubMed ID: 33881447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.
    Blackmon AL; Pinter-Brown L
    Drug Des Devel Ther; 2020; 14():3747-3754. PubMed ID: 32982179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mogamulizumab-associated rash - Case series and review of the literature.
    Hansen I; Abeck F; Menz A; Schneider SW; Booken N
    J Dtsch Dermatol Ges; 2024 Aug; 22(8):1079-1086. PubMed ID: 38924340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care.
    Hawkins N; Muszbek N; Evans R; McNamara L; Jones T
    J Comp Eff Res; 2023 Oct; 12(10):e230017. PubMed ID: 37642410
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mogamulizumab in the treatment of advanced mycosis fungoides and Sézary syndrome: safety and efficacy.
    Lewis DJ; Rook AH
    Expert Rev Anticancer Ther; 2020 Jun; 20(6):447-452. PubMed ID: 32320304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome.
    Beylot-Barry M; Booken N; Weishaupt C; Scarisbrick J; Wu W; Rosen JP; Medley MC
    J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):311-316. PubMed ID: 35993803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T-cell lymphoma and atopy: is there an association?
    Mehrany K; El-Azhary RA; Bouwhuis SA; Pittelkow MR
    Br J Dermatol; 2003 Nov; 149(5):1013-7. PubMed ID: 14632807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
    Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
    An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial.
    Horwitz S; Zinzani PL; Bagot M; Kim YH; Moskowitz AJ; Porcu P; Dwyer K; Sun W; Herr FM; Scarisbrick J
    Leuk Lymphoma; 2021 Dec; 62(13):3109-3118. PubMed ID: 34304674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas.
    Gaydosik AM; Stonesifer CJ; Khaleel AE; Geskin LJ; Fuschiotti P
    Clin Cancer Res; 2022 Jun; 28(12):2610-2622. PubMed ID: 35421230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series.
    Trum NA; Zain J; Martinez XU; Parekh V; Afkhami M; Abdulla F; Carson KR; Rosen ST; Bennett CL; Querfeld C
    Br J Dermatol; 2022 Jan; 186(1):153-166. PubMed ID: 34427917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.
    Franceschi J; Ehret M; Visseaux L; Durlach A; Barbe C; Durot É; Grange F
    Acta Derm Venereol; 2022 Mar; 102():adv00676. PubMed ID: 35083494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time for new biomarkers in mycosis fungoides/Sézary syndrome is here.
    Ortiz-Romero PL
    Br J Dermatol; 2021 Aug; 185(2):250-251. PubMed ID: 34096050
    [No Abstract]   [Full Text] [Related]  

  • 16. Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome.
    Baron MK; Osborn JD; Tao R; Lee CJ
    Leuk Lymphoma; 2020 Jan; 61(1):231-233. PubMed ID: 31452419
    [No Abstract]   [Full Text] [Related]  

  • 17. Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem.
    Larocca C; Kupper TS; LeBoeuf NR
    Clin Cancer Res; 2019 Dec; 25(24):7272-7274. PubMed ID: 31615932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mogamulizumab and bexarotene are a promising association for the treatment of advanced cutaneous T-cell lymphomas: a case series.
    Teoli M; Mandel VD; Franceschini C; Saraceni PL; Cicini MP; Ardigò M
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):8118-8128. PubMed ID: 36394762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapies for mycosis fungoides/Sézary syndrome: biologic rationale and recommendations.
    Lewis DJ; Rook AH
    Int J Dermatol; 2021 Sep; 60(9):e362-e364. PubMed ID: 33559132
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS).
    Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F
    Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.